BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10383148)

  • 21. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
    Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide ligands that bind IgM antibodies and block interaction with antigen.
    Glee PM; Pincus SH; McNamer DK; Smith MJ; Burritt JB; Cutler JE
    J Immunol; 1999 Jul; 163(2):826-33. PubMed ID: 10395676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phage peptide display.
    Newton J; Deutscher SL
    Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential responses of spinal axons to transection: influence of the NG2 proteoglycan.
    de Castro R; Tajrishi R; Claros J; Stallcup WB
    Exp Neurol; 2005 Apr; 192(2):299-309. PubMed ID: 15755547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of NG2 proteoglycan during endochondral and intramembranous ossification.
    Fukushi J; Inatani M; Yamaguchi Y; Stallcup WB
    Dev Dyn; 2003 Sep; 228(1):143-8. PubMed ID: 12950088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells.
    Fukuda MN; Ohyama C; Lowitz K; Matsuo O; Pasqualini R; Ruoslahti E; Fukuda M
    Cancer Res; 2000 Jan; 60(2):450-6. PubMed ID: 10667600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NG2 proteoglycan expression in the peripheral nervous system: upregulation following injury and comparison with CNS lesions.
    Rezajooi K; Pavlides M; Winterbottom J; Stallcup WB; Hamlyn PJ; Lieberman AR; Anderson PN
    Mol Cell Neurosci; 2004 Apr; 25(4):572-84. PubMed ID: 15080887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.
    Ozerdem U
    Prostate; 2006 Feb; 66(3):294-304. PubMed ID: 16245280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combinatorial discovery of tumor targeting peptides using phage display.
    Landon LA; Deutscher SL
    J Cell Biochem; 2003 Oct; 90(3):509-17. PubMed ID: 14523985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Instructive niches: environmental instructions that confound NG2 proteoglycan expression and the fate-restriction of CNS progenitors.
    Sellers DL; Horner PJ
    J Anat; 2005 Dec; 207(6):727-34. PubMed ID: 16367800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing biomolecular interactions of glutathione transferase M2-2 by using peptide phage display.
    Edalat M; Pettersson S; Persson MA; Mannervik B
    Chembiochem; 2002 Sep; 3(9):823-8. PubMed ID: 12210982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
    Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
    Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a decapeptide with the binding reactivity for tumor-associated TAG72 antigen from a phage displayed library.
    Gui J; Moyana T; Malcolm B; Xiang J
    Proteins; 1996 Mar; 24(3):352-8. PubMed ID: 8778782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of tumor-targeting agents on freshly excised human breast tumors using a phage display library.
    Shukla GS; Krag DN
    Oncol Rep; 2005 Apr; 13(4):757-64. PubMed ID: 15756454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy.
    Hibino S; Shibuya M; Engbring JA; Mochizuki M; Nomizu M; Kleinman HK
    Cancer Res; 2004 Jul; 64(14):4810-6. PubMed ID: 15256450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accumulation of macrophage-like cells expressing NG2 proteoglycan and Iba1 in ischemic core of rat brain after transient middle cerebral artery occlusion.
    Matsumoto H; Kumon Y; Watanabe H; Ohnishi T; Shudou M; Chuai M; Imai Y; Takahashi H; Tanaka J
    J Cereb Blood Flow Metab; 2008 Jan; 28(1):149-63. PubMed ID: 17565360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
    J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human melanoma/NG2 chondroitin sulfate proteoglycan is expressed in the sarcolemma of postnatal human skeletal myofibers. Abnormal expression in merosin-negative and Duchenne muscular dystrophies.
    Petrini S; Tessa A; Carrozzo R; Verardo M; Pierini R; Rizza T; Bertini E
    Mol Cell Neurosci; 2003 Jun; 23(2):219-31. PubMed ID: 12812755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma.
    Wiranowska M; Ladd S; Smith SR; Gottschall PE
    Brain Cell Biol; 2006 Jun; 35(2-3):159-72. PubMed ID: 17957481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2.
    Barritt DS; Pearn MT; Zisch AH; Lee SS; Javier RT; Pasquale EB; Stallcup WB
    J Cell Biochem; 2000 Aug; 79(2):213-24. PubMed ID: 10967549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.